MedTrace Logo

GonoScreen: Efficacy of Screening STIs in MSM

NCT04269434 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1014

Last updated 2024-10-16

Study results available
· View outcomes & findings →

Summary

A Multicentre, controlled, randomized trial of 3 site (urethra, pharynx and rectum) sampling performed every 3 months (3x3) for Neisseria gonorrhoea (Ng)/Chlamydia trachomatis (Ct) screening (comparator) vs. no screening (intervention).

Conditions

  • Neisseria Gonorrhoeae Infection
  • Chlamydia Trachomatis Infection

Interventions

OTHER

No Screening

the STI Laboratory will only process the samples/report the results from the non-screening arm at the end of the study.

Sponsors & Collaborators

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Chris Kenyon, MD · Institute of Tropical Medicine Antwerp

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04269434 on ClinicalTrials.gov